231 related articles for article (PubMed ID: 26762671)
1. Cerebrospinal fluid lipocalin 2 in patients with clinically isolated syndromes and early multiple sclerosis.
Khalil M; Renner A; Langkammer C; Enzinger C; Ropele S; Stojakovic T; Scharnagl H; Bachmaier G; Pichler A; Archelos JJ; Fuchs S; Seifert-Held T; Fazekas F
Mult Scler; 2016 Oct; 22(12):1560-1568. PubMed ID: 26762671
[TBL] [Abstract][Full Text] [Related]
2. Cerebrospinal fluid transferrin levels are reduced in patients with early multiple sclerosis.
Khalil M; Riedlbauer B; Langkammer C; Enzinger C; Ropele S; Stojakovic T; Scharnagl H; Culea V; Petzold A; Teunissen C; Archelos JJ; Fuchs S; Fazekas F
Mult Scler; 2014 Oct; 20(12):1569-77. PubMed ID: 24777275
[TBL] [Abstract][Full Text] [Related]
3. Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Cantó E; Tintoré M; Villar LM; Borrás E; Alvarez-Cermeño JC; Chiva C; Sabidó E; Rovira A; Montalban X; Comabella M
J Neuroinflammation; 2014 Nov; 11():181. PubMed ID: 25406498
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of free light chains lambda and kappa in early multiple sclerosis.
Voortman MM; Stojakovic T; Pirpamer L; Jehna M; Langkammer C; Scharnagl H; Reindl M; Ropele S; Seifert-Held T; Archelos JJ; Fuchs S; Enzinger C; Fazekas F; Khalil M
Mult Scler; 2017 Oct; 23(11):1496-1505. PubMed ID: 27899552
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.
Khalil M; Langkammer C; Pichler A; Pinter D; Gattringer T; Bachmaier G; Ropele S; Fuchs S; Enzinger C; Fazekas F
Neurology; 2015 Jun; 84(24):2396-402. PubMed ID: 25979698
[TBL] [Abstract][Full Text] [Related]
6. Remyelination modulators in multiple sclerosis patients.
Al-Temaimi R; AbuBaker J; Al-Khairi I; Alroughani R
Exp Mol Pathol; 2017 Dec; 103(3):237-241. PubMed ID: 29108879
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
Gaetani L; Eusebi P; Mancini A; Gentili L; Borrelli A; Parnetti L; Calabresi P; Sarchielli P; Blennow K; Zetterberg H; Di Filippo M
Mult Scler Relat Disord; 2019 Oct; 35():228-232. PubMed ID: 31404762
[TBL] [Abstract][Full Text] [Related]
8. Decreased levels of alpha-synuclein in cerebrospinal fluid of patients with clinically isolated syndrome and multiple sclerosis.
Antonelou RCh; Emmanouilidou E; Gasparinatos G; Velona T; Voumvourakis KI; Stefanis L
J Neurochem; 2015 Aug; 134(4):748-55. PubMed ID: 25962981
[TBL] [Abstract][Full Text] [Related]
9. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
Khalil M; Enzinger C; Langkammer C; Tscherner M; Wallner-Blazek M; Jehna M; Ropele S; Fuchs S; Fazekas F
Mult Scler; 2009 Sep; 15(9):1048-54. PubMed ID: 19556316
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neurofilament light levels mark grey matter volume in clinically isolated syndrome suggestive of multiple sclerosis.
Tortorella C; Direnzo V; Ruggieri M; Zoccolella S; Mastrapasqua M; D'Onghia M; Paolicelli D; Cuonzo FD; Gasperini C; Trojano M
Mult Scler; 2018 Jul; 24(8):1039-1045. PubMed ID: 28537100
[TBL] [Abstract][Full Text] [Related]
11. Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosis.
Fialová L; Bartos A; Svarcová J; Zimova D; Kotoucova J; Malbohan I
J Neuroimmunol; 2013 Sep; 262(1-2):113-20. PubMed ID: 23870535
[TBL] [Abstract][Full Text] [Related]
12. Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Cantó E; Tintoré M; Villar LM; Costa C; Nurtdinov R; Álvarez-Cermeño JC; Arrambide G; Reverter F; Deisenhammer F; Hegen H; Khademi M; Olsson T; Tumani H; Rodríguez-Martín E; Piehl F; Bartos A; Zimova D; Kotoucova J; Kuhle J; Kappos L; García-Merino JA; Sánchez AJ; Saiz A; Blanco Y; Hintzen R; Jafari N; Brassat D; Lauda F; Roesler R; Rejdak K; Papuc E; de Andrés C; Rauch S; Khalil M; Enzinger C; Galimberti D; Scarpini E; Teunissen C; Sánchez A; Rovira A; Montalban X; Comabella M
Brain; 2015 Apr; 138(Pt 4):918-31. PubMed ID: 25688078
[TBL] [Abstract][Full Text] [Related]
13. Role of lipocalin-2 in brain injury after intracerebral hemorrhage.
Ni W; Zheng M; Xi G; Keep RF; Hua Y
J Cereb Blood Flow Metab; 2015 Sep; 35(9):1454-61. PubMed ID: 25853903
[TBL] [Abstract][Full Text] [Related]
14. Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing-remitting multiple sclerosis.
Ahlbrecht J; Martino F; Pul R; Skripuletz T; Sühs KW; Schauerte C; Yildiz Ö; Trebst C; Tasto L; Thum S; Pfanne A; Roesler R; Lauda F; Hecker M; Zettl UK; Tumani H; Thum T; Stangel M
Mult Scler; 2016 Aug; 22(9):1202-14. PubMed ID: 26493127
[TBL] [Abstract][Full Text] [Related]
15. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
16. Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome.
Rouwette M; Somers K; Govarts C; De Deyn PP; Hupperts R; Van Wijmeersch B; De Jong BA; Verbeek MM; Van Pesch V; Sindic C; Villar LM; Álvarez-Cermeño JC; Stinissen P; Somers V
J Neurochem; 2012 Nov; 123(4):568-77. PubMed ID: 22958230
[TBL] [Abstract][Full Text] [Related]
17. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
[TBL] [Abstract][Full Text] [Related]
18. Serum and CSF measles antibody levels increase over time in patients with multiple sclerosis or clinically isolated syndrome.
Ahlgren C; Odén A; Bergström T; Lycke J
J Neuroimmunol; 2012 Jun; 247(1-2):70-4. PubMed ID: 22498098
[TBL] [Abstract][Full Text] [Related]
19. Identification of candidate biomarkers in converting and non-converting clinically isolated syndrome by proteomics analysis of cerebrospinal fluid.
Timirci-Kahraman O; Karaaslan Z; Tuzun E; Kurtuncu M; Baykal AT; Gunduz T; Tuzuner MB; Akgun E; Gurel B; Eraksoy M; Kucukali CI
Acta Neurol Belg; 2019 Mar; 119(1):101-111. PubMed ID: 29873030
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD27 Levels in Cerebrospinal Fluid as a Prognostic Biomarker in Clinically Isolated Syndrome.
van der Vuurst de Vries RM; Mescheriakova JY; Runia TF; Jafari N; Siepman TA; Hintzen RQ
JAMA Neurol; 2017 Mar; 74(3):286-292. PubMed ID: 28055081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
